The global fluoroscopy and mobile c-arms market size was valued at USD 4.71 billion in 2025 and is projected to grow from USD 4.90 billion in 2026 to USD 6.71 billion by 2034, registering a CAGR of 4.01% during the forecast period from 2026 to 2034. North America dominated the fluoroscopy and mobile c-arms market with a market share of 38.5% in 2025.
Fluoroscopy and mobile C-arms are medical imaging technologies that provide real-time X-ray images to visualize internal structures and guide diagnostic and surgical procedures. Fluoroscopy systems continuously capture moving images, while mobile C-arms are portable imaging devices with a C-shaped arm that allows flexible positioning around the patient. These technologies are widely used in orthopedics, cardiology, gastroenterology, pain management, and emergency care to support accurate diagnosis, image-guided interventions, and minimally invasive procedures while improving precision and patient safety.
Download a Free Sample To learn more about this report,
Integration of Advanced Navigation Into Mobile C-Arms
Mobile C-arms are evolving beyond conventional two-dimensional fluoroscopy toward systems that combine imaging with navigation and image-fusion capabilities. These technologies can help clinicians visualize anatomy and instruments during complex procedures while reducing the need to move patients between imaging systems. The integration of navigation into mobile platforms is supporting fluoroscopy and mobile c-arms market growth by expanding the role of C-arms in vascular, orthopedic, and other image-guided procedures.
For instance, in 2025, Ziehm Imaging highlighted the integration of endovascular navigation with image fusion into a mobile C-arm, allowing aorto-iliac procedures to be planned and navigated directly within the operating room.
Greater Focus on Compact and Flexible Intraoperative Imaging
The market is also moving toward compact imaging platforms that provide greater flexibility around the operating table. Smaller footprints, cable-free designs, improved mobility, and enhanced patient access can help surgical teams adapt imaging equipment to different procedures and operating-room configurations. This shift is expanding fluoroscopy and mobile c-arms market trends toward more flexible intraoperative imaging solutions.
For instance, in December 2025, GE HealthCare unveiled Allia Moveo, a compact cable-free C-arm designed to improve mobility and accessibility in the interventional suite.
Expansion of Mobile Imaging Across Surgical Specialties
Mobile fluoroscopy is used across orthopedic, vascular, urological, neurological, trauma, and other surgical procedures because it provides real-time visualization during interventions. The ability to position a mobile system directly around the operating table makes C-arms useful where immediate intraoperative imaging is required. Expansion into multiple surgical applications is therefore supporting fluoroscopy and mobile c-arms market demand.
For instance, in April 2025, A.T.S. Applicazione Tecnologie Speciali received FDA clearance for its Persona C HR mobile C-arm, which is indicated for multiple surgical applications including orthopedic, vascular, cardiac, thoracic, pain-therapy, and urological procedures.
High Equipment and Ownership Costs Can Limit Adoption
Mobile C-arms require substantial investment in imaging hardware, specialized detectors, generators, service contracts, and supporting infrastructure. Advanced systems incorporating higher-resolution imaging, navigation, or three-dimensional capabilities can further increase acquisition and lifecycle costs. These financial requirements can make it difficult for smaller hospitals and facilities with constrained capital budgets to replace older equipment or expand their mobile imaging fleets.
For instance, in June 2025, GE HealthCare expanded its imaging portfolio with the OEC 3D C-arm, adding three-dimensional imaging capabilities to its mobile surgical imaging offering and illustrating the continued development of higher-capability systems within the mobile C-arm segment.
Development of Three-Dimensional Mobile Imaging for Complex Procedures
Three-dimensional imaging capabilities are creating opportunities for mobile C-arms to support procedures that require more detailed anatomical visualization than conventional fluoroscopy. Intraoperative 3D imaging can assist with implant positioning, anatomical localization, and procedural verification without necessarily requiring patients to leave the operating room. These capabilities are creating new fluoroscopy and mobile c-arms market opportunities in advanced surgical applications.
For instance, in April 2025, research published in The Spine Journal compared effective radiation doses from intraoperative 3D imaging using mobile and fixed C-arms with CT imaging for lumbar-spine assessment, supporting continued development of optimized intraoperative 3D imaging.
Maintaining Image Quality Across Diverse Surgical Conditions
Mobile C-arms must produce diagnostically useful images across different anatomical regions, patient sizes, surgical positions, implants, and operating-room configurations. Variations in anatomy and the presence of metallic instruments or implants can affect image quality and create demands for improved detectors, image processing, positioning, and workflow optimization. Maintaining consistently useful visualization across these conditions remains a technical challenge for manufacturers and clinical teams.
For instance, in September 2025, researchers published work in the Journal of Applied Clinical Medical Physics comparing radiation output and shielding considerations across mobile C-arm systems, highlighting how differences in system characteristics and operating conditions can affect imaging performance and clinical use.
Fluoroscopy Systems Segment Dominated the Fluoroscopy and Mobile C-Arms Market with 57.6% Share in 2025
The fluoroscopy systems segment dominated the global fluoroscopy and mobile C-arms market with a 57.6% share in 2025, driven by the increasing demand for real-time diagnostic imaging and image-guided medical procedures. Fluoroscopy systems enable physicians to visualize internal organs, blood vessels, bones, and soft tissues during minimally invasive interventions, improving procedural accuracy and patient outcomes. Their widespread use across cardiology, orthopedics, gastroenterology, and vascular procedures, along with continuous advancements in digital imaging technology and radiation dose optimization, continues to support the growth of this segment.
The mobile C-arms segment is witnessing steady growth due to their portability, flexibility, and ability to provide high-quality intraoperative imaging across multiple clinical settings. These systems are increasingly used in operating rooms, emergency departments, and ambulatory surgical centers for orthopedic, trauma, pain management, and vascular procedures, allowing healthcare providers to perform image-guided interventions with greater efficiency and precision.
Request Customizationto receive a tailored report.
Neurology Segment is Projected to Register the Fastest Growth in the Fluoroscopy and Mobile C-Arms Market at a CAGR of 6.4%
The neurology segment is projected to register the fastest growth in the fluoroscopy and mobile C-arms market at a CAGR of 6.4% during 2026–2034, driven by the increasing prevalence of neurological disorders and growing demand for minimally invasive neurovascular procedures. Fluoroscopic imaging plays an important role in spinal surgeries, neurointerventional procedures, and pain management by providing real-time visualization that enhances procedural precision while reducing surgical risks. Ongoing advancements in imaging technology continue to improve the effectiveness of neurological interventions.
The orthopedics segment continues to account for the largest share of the market due to the extensive use of fluoroscopy and mobile C-arms during fracture fixation, joint replacement, trauma surgery, and spinal procedures. The cardiology segment remains a major application area for catheter-based interventions and vascular imaging, while the oncology segment utilizes fluoroscopic guidance during cancer diagnosis and minimally invasive treatment procedures. The other segment supports demand across gastroenterology, urology, pain management, and various surgical specialties requiring real-time imaging guidance.
Hospitals Segment Dominated the Fluoroscopy and Mobile C-Arms Market with 66.7% Share in 2025
The hospitals segment dominated the global fluoroscopy and mobile C-arms market with a 66.7% share in 2025, driven by the high volume of diagnostic imaging procedures, surgical interventions, and emergency care services performed in hospital settings. Hospitals continue to invest in advanced fluoroscopy systems and mobile C-arms to support a wide range of specialties, including orthopedics, cardiology, neurology, and vascular surgery. The availability of skilled healthcare professionals, advanced imaging infrastructure, and comprehensive patient care services continues to reinforce the segment's leading position.
The diagnostic centers segment continues to witness steady growth as demand increases for outpatient diagnostic imaging, early disease detection, and cost-effective imaging services. These facilities are expanding their imaging capabilities to improve patient access and reduce hospital workloads. The other segment, including ambulatory surgical centers and specialty clinics, continues to adopt fluoroscopy and mobile C-arm systems to support minimally invasive procedures, improve workflow efficiency, and deliver high-quality patient care across diverse clinical environments.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest share of the global fluoroscopy and mobile C-arms market, representing 38.5% of total revenue and reaching USD 1.81 billion in 2025. The region continues to lead due to its advanced healthcare infrastructure, growing number of minimally invasive procedures, and widespread adoption of image-guided surgical technologies. Rising investments in diagnostic imaging equipment, increasing healthcare expenditure, and continuous technological advancements are supporting steady market growth.
The US market was valued at approximately USD 1.57 billion in 2025, making it the largest contributor in North America. Increasing demand for minimally invasive surgeries, expanding use of advanced imaging systems in hospitals and ambulatory surgical centers, and ongoing investments in healthcare technology continue to strengthen market growth.
Canada's market reached approximately USD 0.24 billion in 2025. Growing adoption of digital imaging technologies, rising healthcare investments, and increasing demand for real-time diagnostic imaging solutions are contributing to steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific accounted for 22.8% of the global fluoroscopy and mobile C-arms market, valued at USD 1.07 billion in 2025, and is projected to register the fastest CAGR of 7.4% during the forecast period. Rapid expansion of healthcare infrastructure, increasing access to advanced diagnostic equipment, rising prevalence of chronic diseases, and growing demand for image-guided surgical procedures continue to drive regional market growth. Government investments in healthcare modernization are further accelerating market expansion.
Japan's market generated approximately USD 0.19 billion in 2025. The country's advanced healthcare system, increasing adoption of minimally invasive procedures, and continuous investment in diagnostic imaging technologies continue to support market growth.
China accounted for the largest share of the Asia Pacific market, reaching approximately USD 0.62 billion in 2025. Expanding hospital infrastructure, increasing healthcare spending, growing demand for high-quality diagnostic imaging, and rising adoption of mobile C-arm systems continue to drive market expansion.
Europe represented 27.4% of the global fluoroscopy and mobile C-arms market, reaching USD 1.29 billion in 2025, and is projected to grow at a CAGR of 5.2% during the forecast period. The regional market is supported by increasing demand for advanced medical imaging systems, expanding adoption of minimally invasive surgical techniques, and continuous investments in healthcare infrastructure. Growing emphasis on early disease diagnosis and precision-guided interventions continues to support long-term market growth.
The UK market was valued at approximately USD 0.28 billion in 2025. Rising investments in diagnostic imaging equipment, growing demand for minimally invasive procedures, and continued modernization of healthcare facilities are supporting market expansion.
Germany's market accounted for approximately USD 0.35 billion in 2025. The country's strong medical technology sector, increasing use of image-guided procedures, and ongoing investments in advanced imaging equipment continue to strengthen market growth.
Middle East & Africa accounted for 5.0% of the global fluoroscopy and mobile C-arms market, totaling USD 0.24 billion in 2025. Increasing healthcare investments, expanding hospital infrastructure, and rising demand for advanced diagnostic imaging systems are supporting market growth across the region. Growing access to specialized surgical procedures is expected to create additional opportunities during the forecast period.
The UAE market was valued at approximately USD 0.05 billion in 2025. Government investments in modern healthcare facilities, increasing adoption of advanced imaging technologies, and growing demand for minimally invasive procedures continue to support market development.
Africa's market reached approximately USD 0.19 billion in 2025. Improving healthcare infrastructure, expanding access to diagnostic imaging services, increasing investments in medical equipment, and rising demand for advanced surgical technologies are creating long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Intrauterine Contraceptive Devices Market Size, Share, Growth, Analysis, 2034
Asia Pacific Medical Screws and Plates Market Size, Share by 2034
Urinary Catheters Market Size, Share, Growth, Forecast, 2034
Light Therapy Market Size, Share, Growth, Analysis, Report, 2034
Latin America Cardiac Resynchronization Therapy (CRT) Market Size, Share and Forecast to 2034
Europe Home Infusion Therapy Market Size, 2034
We are featured on:
sales@straitsresearch.com